Inventor
CARROLL DAVID
US69 patents
⚠️ This page may combine multiple inventors who share the name “CARROLL DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
28 patentsUS7491732B2Feb 17, 2009
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC105 citations99
US7452879B2Nov 18, 2008
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
RIGEL PHARMACEUTICALS INC110 citations99
US7122542B2Oct 17, 2006
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
RIGEL PHARMACEUTICALS INC218 citations99
US7884111B2Feb 8, 2011
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
RIGEL PHARMACEUTICALS INC75 citations98
US7858633B2Dec 28, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC66 citations98
US7560466B2Jul 14, 2009
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
RIGEL PHARMACEUTICALS INC56 citations98
US7947698B2May 24, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC55 citations97
US7834024B2Nov 16, 2010
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC59 citations97
US7754714B2Jul 13, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC39 citations95
US10941134B2Mar 9, 2021
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC18 citations94
US10377742B2Aug 13, 2019
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC20 citations94
US7915273B2Mar 29, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC33 citations93
US9266856B2Feb 23, 2016
AMPK—activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC14 citations92
US8987303B2Mar 24, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8980921B2Mar 17, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8809370B2Aug 19, 2014
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC17 citations92
US7868013B2Jan 11, 2011
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC25 citations91
US10421752B2Sep 24, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC3 citations84
US10259826B2Apr 16, 2019
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
RIGEL PHARMACEUTICALS INC6 citations84
US9732073B2Aug 15, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9725419B2Aug 8, 2017
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC7 citations84
US9248190B2Feb 2, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US8815848B2Aug 26, 2014
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US7585883B2Sep 8, 2009
Substituted pyridines and their uses
RIGEL PHARMACEUTICALS INC10 citations84
US11198689B2Dec 14, 2021
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US9481654B2Nov 1, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC5 citations73
US9409884B2Aug 9, 2016
5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
RIGEL PHARMACEUTICALS INC4 citations70
US11827628B2Nov 28, 2023
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations63
LI HUI
5 patentsUS8415365B2Apr 9, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI31 citations96
US8399472B2Mar 19, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI26 citations96
US8193197B2Jun 5, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI17 citations93
US8410093B2Apr 2, 2013
Cycloalkyl substituted pyrimidinediamine compounds and their uses
LI HUI9 citations84
US8299087B2Oct 30, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI11 citations84
AIREX CORP
4 patentsUS6707200B2Mar 16, 2004
Integrated magnetic bearing
AIREX CORP109 citations94
US7235906B2Jun 26, 2007
Magnetic bearing using displacement winding techniques
AIREX CORP19 citations86
US6651920B2Nov 25, 2003
Method and apparatus for winding and forming motor coil assemblies
AIREX CORP18 citations79
US6433446B1Aug 13, 2002
Linear motor with keyed mounting arrangement
AIREX CORP12 citations68
ARGADE ANKUSH
3 patentsUS9598432B2Mar 21, 2017
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
ARGADE ANKUSH7 citations83
US8809341B2Aug 19, 2014
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
ARGADE ANKUSH9 citations83
US9593082B2Mar 14, 2017
Compositions and methods for inhibition of the JAK pathway
ARGADE ANKUSH3 citations72
SINGH RAJINDER
2 patentsUNIV CLEMSON
2 patentsIntegrated Drive Systems LLC
2 patentsGOFF DANE
1 patentATUEGBU ANDY
1 patentAMAZON TECH INC
1 patentCARROLL BY DESIGN LLC
1 patentShowing the top 50 of 69 patents by PatentIndex Score.